[ORGANIZATION]
belantamab mafodotin
Featured in 2 tracked stories · first seen
Situations
Clinical applications and access of CAR-T and myeloma cell/m
19 clusters · 69 sources · last updated
Latest: CAR-T and CAR-NK therapies show clinical progress in autoimmune and cancer treatments
CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant
Multiple myeloma treatment regulatory approvals
2 clusters · 16 sources · last updated
Latest: AIFA approves belantamab mafodotin for multiple myeloma in Italy
Regulatory authorities have granted approvals for new multiple myeloma treatments in the United States and Italy. In September 2026, the US Food and Drug Administration (FDA) issued accelerated approval for iberdomide.